Surgery Partners, Inc. is classed by the SEC under Services-General Medical & Surgical Hospitals, NEC (industry code 8062), based in Brentwood, TN. Its latest filed balance sheet (2025-12-31) shows total assets of $8.0 billion (its filed statements).
Three tenses, nine metrics. Unseen metrics stay unseen; the grade never fakes a number. Proxy era: provisional values, marked. Weighed as a usage business: prior from its industry code (SEC 8062, Services-General Medical & Surgical Hospitals, NEC); the filing read can change it. All three tenses have at least two readings, so the archetype blend applies as printed.
Headline 3.7 out of ten, 9 of 9 metrics filed: past 3.5 out of ten, present 4.4 out of ten, future 2.9 out of ten. The past asks what it actually did, the present what it is doing right now, the future what it is set up to do next.
Newest annual report: Form 10-K filed 2026-03-02 for the period ended 2025-12-31 (on EDGAR). Newest quarterly report: Form 10-Q filed 2026-08-10 for the period ended 2026-06-30 (on EDGAR). Newest results release: Form 8-K filed 2026-08-10 (on EDGAR). Newest filing: Form 8-K, 2026-09-17. Filings on record since 2015. Read from EDGAR 2026-10-12.
Product and service lines in fiscal 2025: Private Insurance 51%, Government Revenue 42%, Self Pay Revenue 3%, Other Services 3%, Other Patient Service Revenue Sources 2%. As tagged in its annual report (Form 10-K, filed 2026-03-02).
Adlerz, Clifford G (Interim CEO); Evans, Jason Eric (Chief Executive Officer); Oppenheimer, Justin Robert (COO & National Group President); Webb, William Trenton (American Group President); Bane, Harrison R. (National Group President); Doherty, David T (Chief Financial Officer); Baldock, Jennifer (Chief Admin & Dev Officer); Brittenham, Marissa (Chief Strategy Officer); Burkhalter, Danielle (Chief Human Resources Officer); Deluca, Teresa (director); and 6 more. 16 officers and directors have filed their own trades in the last fifteen months, names and titles as filed with the SEC, through 2026-09-30.
This file: Overview · Past · Present · Future · Filings · every company on file
Every stock is a company. We grade the company behind the stock. CrossAssetData is a company research product: no investment advice, no price targets, no price predictions; every claim carries its source, and unseen means unseen. The full file draws when the page's script runs: the essentials, the balance sheet, the estimators, the trend, and every filing of the last ten years.